The Valley Desk

ArticleThe oncologistPublished

Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, Thomas Jefferson University, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
The oncologist
Published
Subject terms
T-Lymphocytes; Humans; Neoplasm Metastasis; Immunotherapy, Adoptive; Prevalence; Male; Prostatic Neoplasms, Castration-Resistant; Safety; prostate cancer; Bispecific Antibodies; Chimeric Antigen Receptor T-cell Therapy; T-cell Engagers
PubMed ID
42081291
PubMed Central ID
PMC13198376
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal